Suppr超能文献

[腺苷脱氨酶抑制剂(EHNA)对离体灌注大鼠心脏缺血再灌注损伤的影响]

[Adenosine deaminase inhibitor (EHNA) on ischemia-reperfusion injury in isolated perfused rat hearts].

作者信息

Zhu Q

机构信息

Cardiovascular Institute, CAMS, Beijing.

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 1990 Apr;18(2):107-9, 127.

PMID:2209402
Abstract

The effects of Erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) on Langendorff perfused rat hearts subjected to ischemia-reperfusion injury were studied. Results showed that EHNA can inhibit the increase of cardiac resting tension during ischemia period and decreasing the incidence of ventricular fibrillation and its duration. The contraction amplitude, resting tension and heart rate could be recovered to preischemic level, and the coronary flow even greater than before. The authors thought that EHNA can block the breakdown of adenosine to inosine and hypothanxine, and, therefore, cut off the pathway and production of oxygen free radicals during ischemia-reperfusion injury.

摘要

研究了赤藓红-9-(2-羟基-3-壬基)腺嘌呤(EHNA)对遭受缺血再灌注损伤的Langendorff灌注大鼠心脏的影响。结果表明,EHNA可抑制缺血期心脏静息张力的增加,并降低室颤发生率及其持续时间。收缩幅度、静息张力和心率可恢复至缺血前水平,且冠脉流量甚至大于缺血前。作者认为,EHNA可阻断腺苷向肌苷和次黄嘌呤的分解,从而切断缺血再灌注损伤期间氧自由基的产生途径和生成。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验